| Code | 9179E | ||||||||||
| MA number | 16/0053/25-S | ||||||||||
| Product Form: | tbl flm 100x30 mg (fľ.HDPE) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 14.03.2025 |
| Validity: | 14.03.2030 |
| PIL: |
PIL_Edoxaban Sandoz 30 mg_03_2025.pdf
|
| SPC: |
SPC_Edoxaban Sandoz 30 mg_03_2025.pdf
|
| Safety feature | Yes |
| Data update: | 19.03.2025 |
